NFKB1 and acute respiratory distress syndrome: Treatment with LYRM03, an ubenimex derivative, can ameliorate the LPS-induced acute lung injury (ALI) in animals by attenuating Myd88-dependent LPS-TLR4 signaling pathway, including the p38 MAPK and IκB/NF-κB pathways (19).